NCT01925859View on ClinicalTrials.gov

EryDex Pharmacokinetics in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Healthy
Interventions
DRUG

EryDex (dexamethasone sodium phosphate encapsulated erythrocytes)

erythrocytes encapsulated with dexamethasone sodium phosphate (EryDex System)-corresponding to either 50 mg OR 125mg of experimental study drug

Trial Locations (1)

21201

SNBL Clinical Pharmacology Center, Baltimore

All Listed Sponsors
lead

Quince Therapeutics S.p.A.

INDUSTRY

NCT01925859 - EryDex Pharmacokinetics in Healthy Volunteers | Biotech Hunter | Biotech Hunter